[Parenchymatous-stromal factors in hemoblastoses].
The data available in the literature data on the role of neoangiogenesis and extracellular matrix factors in the pathogenesis of acute and chronic leukemias and lymphoproliferative diseases are presented. Hematopoiesis and endothelial cells have a common pluripotential progenitor. Angiogenic and fibroblast growth factors are involved chronic leukemia. The phenotype of lymphoid cells determines the type of the cellular and extracellular factors.
Glasko
E N
EN
Kaplanskaia
I B
IB
Frank
G A
GA
D000208:Acute Disease; D043925:Angiogenesis Inducing Agents / Q000378:metabolism*; D000818:Animals; D002908:Chronic Disease; D042783:Endothelial Cells / Q000378:metabolism / Q000473:pathology; D005109:Extracellular Matrix / Q000378:metabolism / Q000473:pathology; D005346:Fibroblast Growth Factors / Q000378:metabolism*; D005347:Fibroblasts / Q000378:metabolism / Q000473:pathology; D006410:Hematopoiesis; D006801:Humans; D007938:Leukemia / Q000378:metabolism* / Q000473:pathology; D008214:Lymphocytes / Q000378:metabolism / Q000473:pathology; D008232:Lymphoproliferative Disorders / Q000378:metabolism* / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000378:metabolism* / Q000473:pathology; D013234:Stem Cells / Q000378:metabolism* / Q000473:pathology
D043925:Angiogenesis Inducing Agents; D005346:Fibroblast Growth Factors